Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	360.60B
Revenue (ttm)	595.36B
Net Income (ttm)	34.97B
Shares Out	11.65M
EPS (ttm)	2,909.22
PE Ratio	10.64
Forward PE	n/a
Dividend	630.00 (2.04%)
Ex-Dividend Date	Aug 20, 2025

Volume	45,285
Average Volume	33,560
Open	30,950
Previous Close	31,100
Day's Range	30,550 - 31,450
52-Week Range	21,800 - 31,950
Beta	0.17
RSI	56.18
Earnings Date	Nov 9, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.